Showing 9051-9060 of 21419 results for "".
Kappa-Opioid Settings: Real-World Evidence Insights
https://reachmd.com/programs/cme/kappa-opioid-settings-real-world-evidence-insights/36300/Review best practices in CKD-aP diagnosis, treatment and management, including the role of multidisciplinary care and shared decision-making to improve quality of life.Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
https://reachmd.com/programs/cme/understanding-igf-1r-inhibition-mechanism-clinical-implications/60944/Explore how experts are rethinking TED severity and integrating modern therapies to personalize treatment and manage individual disease burden.Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
https://reachmd.com/programs/cme/beyond-igf-1r-il-6r-inhibition-and-future-sequencing/60946/Explore how experts are rethinking TED severity and integrating modern therapies to personalize treatment and manage individual disease burden.Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
https://reachmd.com/programs/clinicians-roundtable/data-ntm-lung-disease-care-challenges-impacts/54380/Even as our understanding of nontuberculous mycobacterial (NTM) lung disease advances, major gaps remain, from defining meaningful treatment success to overcoming innate drug resistance. In this conversation with Dr. Alexandria May, Dr. David Griffith shares his perspective on how recent evidence isCalming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis
https://reachmd.com/programs/cme/calming-overactive-immune-response-and-reducing-inflammation-with-tyk2-inhibition-in-psoriasis/50978/Join us to learn about the emerging data with TKY2 inhibitors for treatment of psoriasis.Beyond Cognition: Managing Alzheimer’s as an Integrated Neurodegenerative–Neuropsychiatric Syndrome
https://reachmd.com/programs/cme/Beyond-Cognition-Managing-Alzheimers-as-an-Integrated-Neurodegenerative-Neuropsychiatric-Syndrome/54842/Examine integrated neurodegenerative and neuropsychiatric features of Alzheimer’s disease, including NPS biology and therapeutic strategies.Innovations in Precision Medicine: Leveraging Guideline-Based Immunotherapy and Targeted Treatments in Gynecologic Oncology
https://reachmd.com/programs/cme/Innovations-in-Precision-Medicine-Leveraging-Guideline-Based-Immunotherapy-and-Targeted-Treatments-in-Gynecologic-Oncology/37235/Multidisciplinary experts explore biomarker-driven strategies, immunotherapy, and personalized care in cervical and endometrial cancer management.Playing the Long Game: Improving Durable Control in IBD
https://reachmd.com/programs/cme/playing-the-long-game-improving-durable-control-in-ibd/70184/Explore practical strategies for helping patients with inflammatory bowel disease (IBD) achieve durable disease control, including patient-centered assessment and treat-to-target goals. Watch this on-demand webcast to review expert insights on the latest evidence for advanced therapies in IBD, long-DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.
https://reachmd.com/clinical-practice/oncology-hematology/destiny-breast11-trastuzumab-deruxtecan-followed-by-thp-yields-new-indication-in-the-neoadjuvant-setting/57280/DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.Identifying and Managing Adult Patients with Chronic Immune Thrombocytopenia
https://reachmd.com/programs/medical-industry-feature/adult-chronic-immune-thrombocytopenia-management/56537/Chronic immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low platelet counts and increased bleeding risk, and can have significant impacts on patients’ quality of life.1 Treatment decisions require a personalized approach that considers both clinical factors and patient prefe